NASDAQ: SGHT
Sight Sciences Inc Stock Ownership - Who owns Sight Sciences?

Insider buying vs selling

Have Sight Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jeremy B. HaydenChief Legal Officer2026-04-0613,761$3.55
$48.85kSell
James RodbergChief Financial Officer2026-04-067,231$3.55
$25.67kSell
Alison BauerleinChief Operating Officer2026-04-0225,874$3.48
$90.04kSell
David BadawiChief Technology Officer2026-04-028,168$3.48
$28.42kSell
Paul BadawiPresident and CEO2026-04-0129,244$3.70
$108.20kSell
Brenton TaylorEVP Operations RD2026-04-012,869$3.70
$10.62kSell
David BadawiChief Technology Officer2026-02-1921,270$0.23
$4.89kBuy
Paul BadawiPresident and CEO2026-01-1622,362$6.62
$148.04kSell
David BadawiChief Technology Officer2026-01-164,836$6.62
$32.01kSell
James RodbergChief Financial Officer2026-01-162,616$6.62
$17.32kSell

1 of 6

SGHT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGHT insiders and whales buy or sell their stock.

SGHT Shareholders

What type of owners hold Sight Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Staffan Encrantz12.00%6,478,842$27.34MInsider
Paul Badawi11.39%6,151,156$25.96MInsider
Kck Ltd8.84%4,776,232$20.16MInsider
Long Focus Capital Management LLC6.10%3,292,481$13.89MInstitution
D1 Capital Partners LP5.55%3,000,000$12.66MInsider
Blackrock Inc4.95%2,673,972$11.28MInstitution
Jesse Selnick4.88%2,632,927$11.11MInsider
Andrew Offer4.37%2,358,224$9.95MInsider
David Badawi3.69%1,990,290$8.40MInsider
Vanguard Group Inc3.61%1,948,647$8.22MInstitution

1 of 3

SGHT vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGHT36.19%57.47%Net BuyingNet Selling
ELMD34.45%65.55%Net Selling
SENS3.50%96.50%Net SellingNet Buying
PROF41.99%1.62%Net Buying
MASS54.75%45.25%Net SellingNet Selling

Sight Sciences Stock Ownership FAQ

Who owns Sight Sciences?

Sight Sciences (NASDAQ: SGHT) is owned by 36.19% institutional shareholders, 57.47% Sight Sciences insiders, and 6.34% retail investors. Staffan Encrantz is the largest individual Sight Sciences shareholder, owning 6.48M shares representing 12.00% of the company. Staffan Encrantz's Sight Sciences shares are currently valued at $28.05M.

If you're new to stock investing, here's how to buy Sight Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.